"Stroke risk, advanced" panel

"The Stroke Risk, Advanced" panel is an expanded and maximally informative examination that provides a comprehensive assessment of your likelihood of developing a stroke and allows you to take effective action to keep you healthy.

• Complete blood count (CBC): Helps assess overall blood health, detect anaemia, inflammation and other conditions that may affect stroke risk.
• Lipid profile: Total cholesterol, HDL, LDL, atherogenicity index. Helps assess the risk of developing atherosclerotic plaques in the blood vessels.
• Indicators of carbohydrate metabolism: glycated haemoglobin (HbA1c). Reflects average blood sugar levels over the past 2-3 months, giving a more accurate picture of glycaemic control. Prolonged hyperglycaemia damages blood vessels, making them more vulnerable to atherosclerosis and thrombosis.
• High-sensitivity C-reactive protein cardio : Elevated levels indicate chronic inflammation in the vascular wall, which is a risk factor for atherosclerosis, thrombosis and consequent cardiovascular events;
• Homocysteine: An amino acid whose elevated levels are associated with an increased risk of atherosclerosis and thrombosis, which can lead to stroke;
• Coagulogram (Haemostasis) Profile: An assessment of the blood clotting system;
• D-dimer: marker of activation of the clotting system and fibrinolysis (clot dissolution). Elevated D-dimer levels may indicate an increased risk of thrombosis, which is an important risk factor for ischaemic stroke.
• Lipoprotein (a): A genetically determined risk factor for cardiovascular disease, including stroke. High levels of Lp(a) contribute to the formation of atherosclerotic plaques, making them more unstable and prone to rupture, which can lead to blood clots and ischaemic stroke.